The Evolution of Interventional Pulmonology Field Over 30 Years


Field leader Carla Lamb, MD, discusses advances to evaluating and treating chronic diseases including lung cancer and COPD in this latest episode.

Episode highlights

0:16 Intro
1:49 The history of the interventional pulmonology subspecialty
7:12 The Rescue Lung, Rescue Life Society
10:04 Technological advances to low-dose CT scan accuracy
17:04 Utility of bronchial stents in lung cancer care
21:55 Bronchial thermoplasty in asthmatic patients
26:01 Assessing a COPD patient for volume reduction
32:58 Rheoplasty and targeted lung denervation
35:39 Cryobiopsy in ILD
38:58 The future of interventional pulmonology
42:35 Outro

It is the 30th anniversary of the establishment of the American Association of Bronchology and Interventional Pulmonology (AABIP), one of the first medical organizations to provide specific resources to care providers treating and diagnosing leading causes of pulmonary death including lung cancer and COPD.

In just 3 decades, the subspecialty field of interventional pulmonology has grown to receive its own certification and an exponentionally increasing relevance in treatment strategies and research into these chronic lung disease. Much has been accomplished in short time—but there’s even more promising work on the horizon.

The June 2022 episode of Lungcast features an interview between American Lung Association (ALA) chief medical officer Albert Rizzo, MD, and Carla Lamb, MD, director of interventional pulmonary medicine and the relevant pulmonary fellowship program at Lahey Hospital & Medical Center.

Lamb, an innovator in interventional pulmonology, discusses the young history of the subspecialty, the evolution of low-dose CT scanning capability for lung cancer, COPD evaluations, biopsy strategies, and the future of her field with Rizzo.

Lungcast is a monthly respiratory health podcast series from the ALA produced by HCPLive.

Subscribe or listen to Lungcast on your favorite platforms:

Related Videos
A panel of 3 experts on COPD
A panel of 3 experts on COPD
A Promising Pipeline for COPD
Projecting Dupilumab's Fit in COPD
What the Ensifentrine FDA Approval Means for COPD
3 KOLs are featured in this program.
3 KOLs are featured in this program.
Video 10 - "Future Treatment Landscape for COPD"
Video 9 - "Emerging Treatment Approaches in COPD"
Pavel Strnad, MD | Credit: RWTH Aachen
© 2024 MJH Life Sciences

All rights reserved.